Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator

Neurology Today in 5
21/04/2022 4 min
Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator

Listen "Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator"

Descargar episodio Ver en sitio original

Episode Synopsis

In this week's podcast, Neurology Today's editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.

More episodes of the podcast Neurology Today in 5

50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia 06/11/2025
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits 16/10/2025
Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists 02/10/2025
Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine 18/09/2025
Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG 04/09/2025
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists 21/08/2025
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" 07/08/2025
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine 17/07/2025
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia 03/07/2025
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. 19/06/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA